Market Value1,508,210,000
Total Holdings77
File Date2021-05-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IHI / iShares Trust - iShares U.S. Medical Devices ETF
KIDS / OrthoPediatrics Corp.
BIO / Bio-Rad Laboratories, Inc.
UNH / UnitedHealth Group Incorporated
ABBV / AbbVie Inc.
VAPO / Vapotherm, Inc.
AMGN / Amgen Inc.
TCRR / Tcr2 Therapeutics Inc
JAZZ / Jazz Pharmaceuticals plc
ZYME / Zymeworks Inc.
GKOS / Glaukos Corporation
US33830X1046 / Five Prime Therapeutics Inc
/ Oxford Immunotec Global PLC
YMAB / Y-mAbs Therapeutics, Inc.
MRK / Merck & Co., Inc.
XENT / Intersect ENT Inc
IBB / iShares Trust - iShares Biotechnology ETF
PSCH / Invesco Exchange-Traded Fund Trust II - Invesco S&P SmallCap Health Care ETF
UHS / Universal Health Services, Inc.
AKU / Akumin Inc
ELV / Elevance Health, Inc.
A / Agilent Technologies, Inc.
HCAT / Health Catalyst, Inc.
BTAI / BioXcel Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
CDXS / Codexis, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
STIM / Neuronetics, Inc.
HRC / Hill-Rom Holdings Inc
QTRX / Quanterix Corporation
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
JNJ / Johnson & Johnson
QDEL / QuidelOrtho Corporation
IONS / Ionis Pharmaceuticals, Inc.
TPTX / Turning Point Therapeutics Inc
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
MEIP / MEI Pharma, Inc.
APTO / Aptose Biosciences Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
NUVA / Nuvasive Inc
XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund
ARNA / Arena Pharmaceuticals Inc
NVTA / Invitae Corporation
CVS / CVS Health Corporation
STRO / Sutro Biopharma, Inc.
CDNA / CareDx, Inc
ALDX / Aldeyra Therapeutics, Inc.
JYNT / The Joint Corp.
SPNE / SeaSpine Holdings Corp
BAX / Baxter International Inc.
EBS / Emergent BioSolutions Inc.
KRTX / Karuna Therapeutics, Inc.
SIEN / Sientra, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
ICUI / ICU Medical, Inc.
MCK / McKesson Corporation
SNY / Sanofi - Depositary Receipt (Common Stock)
LHCG / LHC Group Inc
NVS / Novartis AG - Depositary Receipt (Common Stock)
ITGR / Integer Holdings Corporation
PAYX / Paychex, Inc.
BMY / Bristol-Myers Squibb Company
INSM / Insmed Incorporated
PRGO / Perrigo Company plc
GILD / Gilead Sciences, Inc.
BDX / Becton, Dickinson and Company
WAT / Waters Corporation
HOLX / Hologic, Inc.
AVTR / Avantor, Inc.
AXNX / Axonics, Inc.
SLP / Simulations Plus, Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
PFE / Pfizer Inc.
NVST / Envista Holdings Corporation
CI / The Cigna Group
UTHR / United Therapeutics Corporation
KRYS / Krystal Biotech, Inc.
SYNH / Syneos Health Inc - Class A
OMCL / Omnicell, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
MASS / 908 Devices Inc.
MODN / Model N, Inc.
PRTA / Prothena Corporation plc
AXGN / Axogen, Inc.
CUTR / Cutera, Inc.
HALO / Halozyme Therapeutics, Inc.
SIBN / SI-BONE, Inc.
TNDM / Tandem Diabetes Care, Inc.
ATEC / Alphatec Holdings, Inc.
NEO / NeoGenomics, Inc.
ATRC / AtriCure, Inc.
KRMD / KORU Medical Systems, Inc.
OPRX / OptimizeRx Corporation